Skip to content

Multi-omics study of nasopharyngeal carcinoma based on a prospective cohort

Multi-omics study of nasopharyngeal carcinoma based on a prospective cohort

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126622
Enrollment
Unknown
Registered
2026-06-12
Start date
2026-06-20
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early-stage nasopharyngeal carcinoma

Interventions

Observation group:None

Sponsors

Sun Yat-sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 69 Years

Inclusion criteria

Inclusion criteria: 1.Permanent residents aged 30-69 years in the study screening areas. 2.No prior history of nasopharyngeal carcinoma (NPC). 3.Mentally competent with full consciousness. 4.Provided written informed consent prior to study enrollment.

Exclusion criteria

Exclusion criteria: 1.Patients with severe cardiac, cerebral, pulmonary, hepatic and renal diseases, deaf-mutes, mentally ill individuals and pregnant women. 2.Prior history of nasopharyngeal carcinoma (NPC). 3.Permanent residents whose household registration was not within the study screening areas. 4.Refusal to provide written informed consent before study enrollment.

Design outcomes

Primary

MeasureTime frame
Nasopharyngeal carcinoma diagnostic results;

Secondary

MeasureTime frame
Quantitative result of blood and saliva EBV load;EB virus antibody test results;Detection of high-risk host risk factors;Detection of EBV genome, transcriptome, epigenetics and protein levels;

Countries

China

Contacts

Public ContactMiao Xu

Sun Yat-sen University Cancer Center

xumiao@sysucc.org.cn+86 20 8734 2311

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026